Maximize Oncology Investments at Every Stage of the Product Life Cycle
ZS helps pharmaceutical companies maximize the performance of oncology products throughout their life cycles, from early-stage development and clinical trials to launch planning, execution and product maturation. We have helped our oncology clients, including many industry-leading pharmaceutical and biotech companies, at both the product portfolio and individual product levels.
We help established and emerging oncology clients stay ahead of scientific, clinical and commercial trends that change rapidly. Through deep knowledge of the unique dynamics of treatments, familiarity with the multiplicity of oncology data sources, and a broad perspective on the fast-evolving regulatory and reimbursement environment, ZS can increase the chances of success for your oncology investments.
ZS can help oncology drug manufacturers and oncology diagnostics companies:
- Improve forecasting – Better assess the value of your company’s portfolio by modeling the dynamic epidemiology of cancer treatment and evaluating molecules in the development pipeline.
- Accurately track product performance – Incisively understand product usage in patient segments by using the latest data sources and advanced research methods.
- Sharpen sales force strategy – Determine why sales professionals are getting restricted access to prescribers, and how to change the sales model so that marketing messages get through.
- Raise sales force effectiveness – Provide guidance on the influence of healthcare institutions over the physician prescription decision, and help develop a database on oncologists so that salespeople understand where they practice, their hospital affiliations and other vital information.
ZS Associates brings together multiple areas of expertise—therapeutic depth, qualitative market research and quantitative research skills, modeling and data analysis capabilities, and field experience—to help our clients improve throughout every facet of their path to oncology product commercialization.